14
nanotimes
Companies Facts
with two-position output in two directions for use in zoom lever control of mobile devices such as compact digital cameras and di- gital camcorders. Mass production commenced in February 2012.
A
http://www.alps.com/products/e/npv_product/120301_ SSCQ/SSCQ_E.PDF
T
he Board of Directors of AMCOL International Corporation (NYSE: ACO) has declared a quar-
terly dividend of $0.18 a share for the first quarter of 2012. The first quarter dividend is payable on April 10, 2012 to shareholders of record as of March 6, 2012.
http://www.amcol.com
1.0 GHz to 18.0 GHz highpass / low- pass diplexer, Bias-T from its CMT Filters product group. The CMD837, 1.0 GHz to 18.0 GHz Bias-T,
A
PI Technologies Corp. (NASDAQ: ATNY) announced the availability of its new CMD837,
LPS ELECTRIC EUROPE GmbH has developed the SSCQ Series compact detector switch
is an ideal solution when RF modulation or DC injec- tion is essential.
http://apitech.com
velopment programs in oncology and obesity, an- nounced financial results for its fiscal 2012 first quarter ended December 31, 2011. For the quarter ended December 31, 2011, Arrowhead reported revenues of $23,958, compared to revenue of $296,139 in the quarter ended December 31, 2010. Total operating expenses for the quarter ended December 31, 2011 were $4.1 million, compared to $3.6 million during the quarter ended December 31, 2010.
A
Net loss attributable to Arrowhead for the quarter en- ded December 31, 2011 was $2.5 million, or $0.25 per share based on 10,121,069 weighted average shares outstanding. This compares with a net loss attributable to Arrowhead of $1.4 million, or $0.20 per share based on 7,177,941 weighted average shares outstanding, for the quarter ended December 31, 2010.
The Company‘s net cash used in operations for the quarter ended December 31, 2011 was $2.7 million, compared with $0.9 million for the quarter ended December 31, 2010. Cash provided by investing activities was $0.5 million, primarily due to cash received from the sale of investments. Cash provided by financing activities was $1.4 million, primarily due to the issuanc
rrowhead Research Corporation (NASDAQ: ARWR), a nanomedicine company with de-
12-02 :: February/March 2012
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89